WallSt Focus
Total 1035 Posts
Bitcoin Rebounds Above $91K as Traders Bet on a Year-End Rally
Cryptocurrencies edged higher on Thursday, extending a midweek rebound that lifted Bitcoin back above $91,000 and helped ease pressure across digital assets after weeks of volatility.
Gold Extends Rally as Traders Bet on Fed Rate Cut
Gold prices surged again on Friday, capping a powerful four-month winning streak and edging toward record highs as expectations for a December rate cut solidified.
National CineMedia Wants a Bigger Audience—Here’s How It’s Getting One
National CineMedia is acquiring Spotlight Cinema Networks to expand into premium boutique theaters, boosting its national share and strengthening its presence in major markets like NYC and LA.
Stock Market Today: Stocks Rise to Cap Volatile Month as Nasdaq Ends 7-Month Win Streak
US stocks edged higher in a shortened Black Friday session, closing out a turbulent November with fresh momentum despite lingering worries around tech valuations and the broader economic outlook.
Nanox’s Bold $800K Bet: Can VasoHealthcare IT Jumpstart U.S. AI Imaging?
Nanox’s planned acquisition of VasoHealthcare IT signals a strategic push to speed U.S. adoption of its AI imaging tech by adding nationwide integration, data migration, and deployment expertise.
Genco’s Newcastlemax Buyout: The Quiet Move That Could Supercharge Its Small Cap Story
Genco is adding two modern scrubber-fitted Newcastlemax ships for $145.5M, aiming to boost scale and efficiency as dry bulk supply stays tight and long-haul volumes trend higher.
Sickle-Cell Setback Or Acquisition Setup? Agios’ 48% Drop Could Draw Dealmakers
Agios plunged 48% after its Phase III Pyrukynd trial delivered mixed results, missing key pain-crisis and fatigue endpoints. Despite strong hemoglobin gains, AGIO still seeks FDA approval.